Pendal Group LTD Zoetis Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Pendal Group LTD holds 5,168 shares of ZTS stock, worth $923,935. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,168

Previous 5,811 11.07%

Holding current value

$923,935

Previous $861,000 12.08%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$131.14 - $157.47 $84,323 - $101,253	-643 Reduced 11.07%	5,168 $0
Q3 2022 Oct 18, 2022	BUY	$148.29 - $182.55 $588,859 - $724,906	3,971 Added 215.82%	5,811 $861,000
Q2 2022 Jul 25, 2022	SELL	$155.97 - $200.09 $24,643 - $31,614	-158 Reduced 7.91%	1,840 $316,000
Q1 2022 Apr 25, 2022	SELL	$181.39 - $234.03 $1,813 - $2,340	-10 Reduced 0.5%	1,998 $377,000
Q4 2021 Jan 18, 2022	SELL	$193.69 - $247.03 $462,144 - $589,413	-2,386 Reduced 54.3%	2,008 $490,000
Q3 2021 Nov 05, 2021	BUY	$189.29 - $209.69 $291,506 - $322,922	1,540 Added 53.96%	4,394 $853,000
Q2 2021 Jul 28, 2021	BUY	$155.9 - $187.99 $77,326 - $93,243	496 Added 21.03%	2,854 $532,000
Q1 2021 May 24, 2021	BUY	$144.0 - $169.39 $339,552 - $399,421	2,358 New	2,358 $371,000
Q1 2021 May 03, 2021	SELL	$144.0 - $169.39 $250,704 - $294,907	-1,741 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$157.07 - $174.35 $2,984 - $3,312	19 Added 1.1%	1,741 $288,000
Q3 2020 Nov 02, 2020	SELL	$137.1 - $165.37 $80,614 - $97,237	-588 Reduced 25.45%	1,722 $285,000
Q2 2020 Aug 07, 2020	SELL	$111.92 - $142.53 $281,366 - $358,320	-2,514 Reduced 52.11%	2,310 $317,000
Q1 2020 May 04, 2020	SELL	$92.66 - $144.94 $119,531 - $186,972	-1,290 Reduced 21.1%	4,824 $567,000
Q4 2019 Feb 06, 2020	BUY	$116.25 - $133.25 $127,758 - $146,441	1,099 Added 21.91%	6,114 $809,000
Q3 2019 Nov 12, 2019	SELL	$112.57 - $128.43 $44,915 - $51,243	-399 Reduced 7.37%	5,015 $624,000
Q2 2019 Aug 01, 2019	SELL	$97.98 - $114.28 $2.11 Million - $2.46 Million	-21,569 Reduced 79.94%	5,414 $0
Q1 2019 May 01, 2019	SELL	$81.56 - $100.67 $7,829 - $9,664	-96 Reduced 0.35%	26,983 $0
Q4 2018 Jan 30, 2019	SELL	$79.28 - $95.27 $1,982 - $2,381	-25 Reduced 0.09%	27,079 $2.32 Million
Q3 2018 Nov 05, 2018	SELL	$83.5 - $93.23 $4.12 Million - $4.6 Million	-49,374 Reduced 64.56%	27,104 $0
Q2 2018 Jul 18, 2018	BUY	$79.9 - $89.2 $2.6 Million - $2.9 Million	32,560 Added 74.14%	76,478 $0
Q1 2018 May 08, 2018	BUY	$71.51 - $84.69 $2.55 Million - $3.02 Million	35,620 Added 429.26%	43,918 $0
Q4 2017 Feb 06, 2018	SELL	$63.24 - $72.8 $87,777 - $101,046	-1,388 Reduced 14.33%	8,298 $0
Q3 2017 Nov 01, 2017	BUY	$59.73 - $65.4 $37,988 - $41,594	636 Added 7.03%	9,686 $0
Q2 2017 Aug 11, 2017	BUY	N/A	9,050	9,050 $0

Others Institutions Holding ZTS

# of Institutions

1,923

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account